Hannover Rueck SE
XETRA:HNR1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hannover Rueck SE
XETRA:HNR1
|
DE |
Hannover Rueck SE
Hannover Rueck SE, nestled at the heart of the global reinsurance industry, quietly operates behind the scenes, masterfully dispersing risk for insurance companies around the world. Born in 1966 in Hannover, Germany, this company has steadily built a reputation as one of the leading reinsurance groups globally. Its core business revolves around providing reinsurance solutions that cover both life and health as well as property and casualty sectors. By pooling risks from these insurance policies, Hannover Rueck ensures that its clients—primary insurers—can offer a stable promise to policyholders despite natural disasters, economic shifts, or pandemic outbreaks. This strategic role is essentially akin to providing a financial safety net, allowing their partners to take on new business without the looming threat of catastrophic financial losses.
The financial alchemy that underpins Hannover Rueck’s success is rooted in its meticulous risk assessment and capital management. With an adept ability to quantify and price risk accurately, the reinsurer can charge premiums that reflect exposure while maintaining a balanced risk portfolio. Profit generation stems from the collection of these premiums, coupled with strategic investments of the capital reserves. Hannover Rueck’s prowess in investment further bolsters its financial fortitude, allowing it to amplify returns on equity. By skillfully navigating the intricate web of global risks and leveraging its comprehensive actuarial data and market insights, the company not only sustains its resilience but continually enhances its value proposition to partners and shareholders alike.
Hannover Rueck SE, nestled at the heart of the global reinsurance industry, quietly operates behind the scenes, masterfully dispersing risk for insurance companies around the world. Born in 1966 in Hannover, Germany, this company has steadily built a reputation as one of the leading reinsurance groups globally. Its core business revolves around providing reinsurance solutions that cover both life and health as well as property and casualty sectors. By pooling risks from these insurance policies, Hannover Rueck ensures that its clients—primary insurers—can offer a stable promise to policyholders despite natural disasters, economic shifts, or pandemic outbreaks. This strategic role is essentially akin to providing a financial safety net, allowing their partners to take on new business without the looming threat of catastrophic financial losses.
The financial alchemy that underpins Hannover Rueck’s success is rooted in its meticulous risk assessment and capital management. With an adept ability to quantify and price risk accurately, the reinsurer can charge premiums that reflect exposure while maintaining a balanced risk portfolio. Profit generation stems from the collection of these premiums, coupled with strategic investments of the capital reserves. Hannover Rueck’s prowess in investment further bolsters its financial fortitude, allowing it to amplify returns on equity. By skillfully navigating the intricate web of global risks and leveraging its comprehensive actuarial data and market insights, the company not only sustains its resilience but continually enhances its value proposition to partners and shareholders alike.
Net income: Group net income was a record EUR 2.64 billion for 2025.
Dividend: Proposed dividend EUR 12.50 (up almost 40% YoY), payout ratio 57% and noted as the new minimum for next year.
P&C performance: P&C combined ratio 84%, underlying P&C revenue growth ~10% (FX-adjusted growth 3.8%), large-loss impact EUR 375 million below budget and management used the strong year to add resiliency.
Life & Health: Reinsurance service result EUR 903 million (above target), Life new business CSM up (EUR 755 million for one measure; group new business CSM reported at EUR 3.0 billion).
Investments: Realized fixed-income losses ~EUR 593 million in 2025 (EUR 270 million in Q4); reported return on investment 2.5% for the year (3.4% excluding realized losses); reinvestment yield slightly above 4%.
Capital strength: Solvency ratio 256%; operating capital generation ~EUR 3.7 billion; reserve resiliency increased by around EUR 700 million to a preliminary ~EUR 3.2 billion at year-end 2025.
Guidance: 2026 confirmed: ROI target ~3.5%, Life & Health reinsurance service result ~EUR 925 million, CSM growth midterm target ~2%, P&C combined ratio target <87%.
